SCHEMBL7878034

SCHEMBL7878034

CNC(N)=NC(=O)c1cc2ccc(OCc3cccc(CN)c3)cc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 1/20 0.47
CFD P00746 1/20 0.46
PDGFRB P09619 1/20 0.42
PDGFRA P16234 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
SRD5A2 P31213 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MAOB P27338 7/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
MAOA P21397 2/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
SIRT1 Q96EB6 1/20 0.39
SIRT3 Q9NTG7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7877995 0.93 FLT3 (0.47) FLT3CFDPDGFRBPDGFRAKDM4E
SCHEMBL7877892 0.90 FLT3 (0.45) FLT3CFDPDGFRBPDGFRAKDM4E
Hydrochloric Acid SCHEMBL7877491 0.89 FLT3 (0.57) FLT3CFDPDGFRBPDGFRAKDM4E
SCHEMBL7877501 0.88 KMT2A (0.41) FLT3PDGFRBPDGFRAMEN1KMT2A
SCHEMBL7882351 0.88 CFD (0.44) FLT3CFDPDGFRBPDGFRAKDM4E
SCHEMBL7884907 0.85 FLT3 (0.43) FLT3CFDPDGFRBPDGFRAKDM4E
SCHEMBL7881191 0.85 KMT2A (0.39) FLT3PDGFRBPDGFRAMEN1KMT2A
SCHEMBL7877991 0.85 MAOB (0.38) CFDMAOBMAOAMRGPRX4
SCHEMBL7881585 0.85 FLT3 (0.39) FLT3CFDPDGFRBPDGFRAKDM4E
SCHEMBL7877734 0.83 FLT3 (0.46) FLT3CFDPDGFRBPDGFRAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed